The VitaCore FlowGuard is a subdermal hemodynamic management implant designed to continuously monitor and regulate arterial blood pressure in real time. A mesh of piezoelectric microsensors threads along the outer aortic wall and carotid branches, feeding data to a central microprocessor roughly the size of a flattened grape. When pressure deviates beyond calibrated thresholds — upward during stress events, downward during orthostatic drops — the FlowGuard releases nanodose vasodilators or vasoconstrictors from an integrated reservoir capsule, replenished via quarterly subcutaneous injection at any VitaCore-licensed pharmacy. The system also logs rolling 90-day cardiovascular data to the user's health profile, flagging anomalies for review by a licensed practitioner or the user's personal med-AI.

The FlowGuard is, in the parlance of GLMZ's working-class neighborhoods, simply 'the thing that keeps you from dropping.' Hypertension runs deep in Tier 1 and 2 populations — stress, poor food access, environmental pollutants, shift work that never ends — and the FlowGuard has become as commonplace as corrective lenses once were. Tier 2 factory workers get them subsidized through employer wellness mandates. Older residents on the Shelf scrape together installment payments through VitaCore's LifeCredit program. The implant doesn't cure the conditions that drive high blood pressure; it simply keeps the body from catastrophizing while life continues at its brutal pace. For many users, the most notable daily experience is an absence: no more afternoon headaches behind the eyes, no more waking dizzy, no more sitting down on the transit platform because the world went gray.